NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
15 hedge funds and large institutions have $1.06M invested in InVivo Therapeutics Holdings Corp in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$227K | |
| 2 | +$136K | |
| 3 | +$45K | |
| 4 |
Two Sigma Investments
New York
|
+$23K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15K |
Top Sellers
| 1 | -$288K | |
| 2 | -$172K | |
| 3 | -$132K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$93K |
| 5 |
MPWT
MassMutual Private Wealth & Trust
Windsor,
Connecticut
|
-$4.42K |